IgA vasculitis with nephritis in children

Adv Clin Exp Med. 2020 Apr;29(4):513-519. doi: 10.17219/acem/112566.

Abstract

Immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura (HSP), is the most common form of systemic vasculitis in children. Although the first case of IgAV was described more than 200 years ago, its etiology still remains unclear. Nephrological symptoms are observed in 30-50% of children during the course of the disease, and in up to 91% of cases within 6 weeks of the onset of the first symptoms. Whereas other organ manifestations of IgAV are mostly benign and self-limiting, nephritis may lead to chronic kidney disease (CKD) and end-stage renal disease (ESRD). Appropriate treatment commenced early enough can stop the disease progression. However, even in severe cases there are no evidence-based guidelines, which makes the therapeutic decisions more difficult. In this article, which is the most up-to-date overview regarding IgAV, we discuss the disease's pathogenesis, the clinical forms of renal involvement in the course of the disease, the risk factors for adverse prognosis and treatment options in accordance with current recommendations.

Keywords: children; immunoglobulin A vasculitis; nephritis.

Publication types

  • Review

MeSH terms

  • Child
  • Humans
  • IgA Vasculitis
  • Immunoglobulin A / blood*
  • Immunoglobulin A / immunology
  • Kidney
  • Nephritis / blood
  • Nephritis / etiology
  • Nephritis / immunology*
  • Vasculitis / blood
  • Vasculitis / complications
  • Vasculitis / immunology*

Substances

  • Immunoglobulin A